Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
December 29, 2024
[The distributions of serum HBsAg level in chronic hepatitis B patients based on the China Registry of Hepatitis B (CR-HepB)]
S Y Chen, S Shan, Y Y Kong, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
February 10, 2025
[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]
S Y Chen, S Shan, Y Y Kong, et al.
Plos One
|
July 30, 2015
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial
Brian E Lacy, Ron Schey, Steven J Shiff, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
August 29, 2022
[Analysis of change in esophageal varices and clinical characteristics in hepatitis B virus-related cirrhosis after antiviral therapy]
B Q Wang, X N Wu, J L Zhou, et al.
The American Journal of Gastroenterology
|
September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety
William D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology
|
September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
Satish Rao, Anthony J Lembo, Steven J Shiff, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
November 28, 2023
[Chinese expert guidance on overall application of lenvatinib in hepatocellular carcinoma]
X R Yang, H C Sun, Q Xie, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
July 17, 2023
[The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study]
J J Xu, J Chen, Y X Liu, et al.
The New England Journal of Medicine
|
August 12, 2011
Two randomized trials of linaclotide for chronic constipation
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
August 14, 2023
[Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy]
T Zhang, Y Deng, H Y Kang, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
December 29, 2024
[The distributions of serum HBsAg level in chronic hepatitis B patients based on the China Registry of Hepatitis B (CR-HepB)]
S Y Chen, S Shan, Y Y Kong, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
February 10, 2025
[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]
S Y Chen, S Shan, Y Y Kong, et al.
Plos One
|
July 30, 2015
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial
Brian E Lacy, Ron Schey, Steven J Shiff, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
August 29, 2022
[Analysis of change in esophageal varices and clinical characteristics in hepatitis B virus-related cirrhosis after antiviral therapy]
B Q Wang, X N Wu, J L Zhou, et al.
The American Journal of Gastroenterology
|
September 19, 2012
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety
William D Chey, Anthony J Lembo, Bernard J Lavins, et al.
The American Journal of Gastroenterology
|
September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
Satish Rao, Anthony J Lembo, Steven J Shiff, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
November 28, 2023
[Chinese expert guidance on overall application of lenvatinib in hepatocellular carcinoma]
X R Yang, H C Sun, Q Xie, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
July 17, 2023
[The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study]
J J Xu, J Chen, Y X Liu, et al.
The New England Journal of Medicine
|
August 12, 2011
Two randomized trials of linaclotide for chronic constipation
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
August 14, 2023
[Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy]
T Zhang, Y Deng, H Y Kang, et al.
Page
of 17